ArticleOncotarget2020

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib.

Wayne D Blosser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.